Compare ALSN & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALSN | RDY |
|---|---|---|
| Founded | 1915 | 1984 |
| Country | United States | India |
| Employees | 4000 | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.9B | 11.6B |
| IPO Year | 2011 | 2001 |
| Metric | ALSN | RDY |
|---|---|---|
| Price | $135.53 | $13.65 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 7 | 1 |
| Target Price | ★ $117.57 | $16.90 |
| AVG Volume (30 Days) | 595.9K | ★ 2.3M |
| Earning Date | 05-04-2026 | 05-12-2026 |
| Dividend Yield | ★ 0.79% | 0.53% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 7.33 | N/A |
| Revenue | ★ $3,010,000,000.00 | N/A |
| Revenue This Year | $94.98 | $7.72 |
| Revenue Next Year | $5.30 | $3.50 |
| P/E Ratio | ★ $18.51 | $18.67 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $76.01 | $12.77 |
| 52 Week High | $136.89 | $16.17 |
| Indicator | ALSN | RDY |
|---|---|---|
| Relative Strength Index (RSI) | 72.54 | 54.18 |
| Support Level | $110.01 | $12.93 |
| Resistance Level | N/A | $13.96 |
| Average True Range (ATR) | 3.02 | 0.27 |
| MACD | 1.01 | 0.07 |
| Stochastic Oscillator | 93.20 | 82.55 |
Allison Transmission is the largest manufacturer of fully automatic transmissions for medium- and heavy-duty commercial vehicles. Its automatic transmissions allow customers to achieve better fuel and operator efficiency than less expensive manual and automated manual transmissions. Allison serves several end markets, including on- and off-highway equipment and military vehicles. Its on-highway business commands approximately 60% global market share. The company's transmissions can be found in Class 4-8 trucks, buses, and a limited number of large passenger vehicles (heavy-duty pickup trucks and motorhomes). Allison also produces commercial hybrid propulsion systems and is developing fully electric powertrains.
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.